Pluri Inc. Proceeds from Issuance of Private Placement
Pluri Inc. (PLUR) had Proceeds from Issuance of Private Placement of $10.00 million as of 2024-06-12, per its 10-K filed 2024-09-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2024-09-18
- Pluri Inc. proceeds from issuance of private placement for the quarter ending 2015-03-31 was $586.00K.
| Period end | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement 0 month | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month |
|---|---|---|---|---|---|---|
| 2024-06-12 | $10.00M 10-K · filed 2024-09-18 | |||||
| 2015-03-31 | $586.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $1.11M 10-Q · filed 2015-05-06 | ||||
| 2014-12-31 | $528.00K 10-Q · filed 2015-02-05 | |||||
| 2014-03-31 | $10.15M 10-Q · filed 2015-05-06 | |||||
| 2012-09-30 | $34.11K 10-K · filed 2013-09-11 | |||||
| 2011-02-01 | $38.14M 10-K · filed 2012-09-10 | $38.14K 10-K · filed 2013-09-11 | ||||
| 2010-10-18 | $5.25M 10-K · filed 2012-09-10 | $5.25K 10-K · filed 2013-09-11 | ||||
| 2010-04-27 | $2.68M 10-K · filed 2012-09-10 | |||||
| 2009-10-12 | $3.03M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |